Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 25Carcinoma, Hepatocellular 25Small Cell Lung Carcinoma 16Lung Neoplasms 14Neoplasms 12Breast Neoplasms 9Colorectal Neoplasms 7Carcinoma, Renal Cell 7Squamous Cell Carcinoma of Head and Neck 6Melanoma 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Carcinoma, Transitional Cell 5Stomach Neoplasms 3Solid Tumors 3Sarcoma, Alveolar Soft Part 3Sarcoma 3Prostatic Neoplasms 3Liver Neoplasms 3Glioblastoma 3Extensive Stage Lung Small Cell Carcinoma 3Treatment-Refractory Solid Tumors 2Small Cell Lung Cancer Extensive Stage 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Osteosarcoma 2Nasopharyngeal Carcinoma 2Mesothelioma, Malignant 2

Interventions

Pemetrexed 2Carboplatin 2pembrolizumab 1patritumab deruxtecan 1durvalumab 1atezolizumab 1Taxes 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Small Cell Lung Cancer Metastatic × atezolizumab × 90 days × Clear all
NCT05689671 2026-03-10

ANTELOPE

Charite University, Berlin, Germany

Phase 4 Active not recruiting
136 enrolled
Thoracic

Non-Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡